Original Research
Accepted on 30 Dec 2024
Comparative Study on the Bioavailability and Bioequivalence of Rifapentine Capsules in Humans
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1463575
Type at least 3 characters
745 articles
Articles
Original Research
Accepted on 30 Dec 2024
Revised Main Text (all changes shown in red) Characterizing the Plasma Protein Binding Profiles of Chemistry Diversified Antisense Oligonucleotides in Human and Mouse Plasma Using an Ultrafiltration Method
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1481937
Original Research
Accepted on 27 Dec 2024
Novel (Q)SAR Models for Prediction of Reversible and Time-Dependent Inhibition of Cytochrome P450 Enzymes Authors
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1451164
Review
Accepted on 23 Dec 2024
Contribution and expression of renal drug transporters in renal cell carcinoma
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466877
Original Research
Accepted on 23 Dec 2024
Pharmacokinetics of 7,8-Dihydroxyflavone in Neonatal Mice with Hypoxia-Ischemia Related Brain Injury
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1508696
Original Research
Accepted on 19 Dec 2024
Evaluation of Drug-Drug Interaction between Suraxavir Marboxil (GP681) and Itraconazole, and Assessment of the Impact of Gene Polymorphism
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505557
Original Research
Published on 19 Dec 2024
Pharmacokinetics, bioavailability, and tissue distribution of MRTX1133 in rats using UHPLC-MS/MS
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1509319
- 324 views
Original Research
Accepted on 18 Dec 2024
stormTB: A web-based simulator of a murine minimal-PBPK model for anti-tuberculosis treatments
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1462193
Original Research
Accepted on 18 Dec 2024
LC-MS/MS assisted pharmacokinetic and tissue distribution study of ropivacaine and 3-OH-ropivacaine on rats after plane block anesthesia
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494646
Original Research
Accepted on 18 Dec 2024
Effect of Low-Frequency Nnon-Focus Ultrasound Combined with Microbubbles Therapy on Tumor Hhypoxic Microenvironment
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1502349
Original Research
Accepted on 17 Dec 2024
Effects of acteoside from Cistanche tubulosa on the plasma metabolome of Cancer-related fatigue mice inoculated with colon cancer cells
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1370264
Original Research
Accepted on 17 Dec 2024
The in vivo metabolic pathway of Deg-AZM and in vitro investigations into the contribution of drug metabolizing enzymes and drug transporters in the drug interactions of Deg-AZM, a clinical-stage new transgelin agonist
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1510903
Original Research
Published on 16 Dec 2024
Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1452526
- 250 views
Original Research
Accepted on 13 Dec 2024
Amphotericin B Tissue Penetration and Pharmacokinetics in Healthy and Candida albicans-Infected Rats: Insights from Microdialysis and Population Modeling
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1515462
Original Research
Accepted on 11 Dec 2024
The effects of clinical and pharmacological factors on the ratio of clozapine to norclozapine in psychiatric patients
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1518739
Clinical Trial
Accepted on 09 Dec 2024
Evaluating the pharmacokinetics and safety of Blonanserin tablets and Lonasen ® : A randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trial
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1511214